top of page

MT2

$25.00Price
Size
Quantity
Expedited ⚡ Pre-Order: Ships within 3-5 days 📦

📝LAB NOTES


MELANOTAN II (MT-II)

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH). It acts as a nonselective melanocortin receptor agonist and is studied for its interactions with melanocortin signaling pathways involved in pigmentation, energy regulation and neuroendocrine activity.


TARGETED RESEARCH USE

Melanotan II is primarily investigated for its influence on melanocortin receptors and melanin-producing pathways. Research has examined its effects on melanogenesis and pigmentation through melanocortin-1 receptor signaling.

Because Melanotan II interacts with multiple melanocortin receptor subtypes, it has also been used experimentally to study appetite, energy expenditure, metabolic signaling and centrally mediated physiological responses. These broader effects make MT-II a useful research compound for investigating the diverse functions of the melanocortin system.


RESEARCH REFERENCES

Evaluation of Melanotan II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical Study

Role of the Melanocortin-4 Receptor in Metabolic Rate and Food Intake in Mice

MT-II Induces Penile Erection via Brain and Spinal Mechanisms


Research Note: Melanotan II is a nonselective melanocortin receptor agonist. Its activity across multiple receptor subtypes distinguishes it from compounds designed to interact more selectively with a single melanocortin pathway.


Melanotan II is supplied as a lyophilized powder in a sealed 3 mL vial. Reconstitution is required before laboratory analysis.


⚠️ FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL USE

    DISCLAIMER:

    Research Use Only: Products sold by PureForma Labz are intended strictly for laboratory research purposes only. They are not for human consumption, animal use, veterinary use, or therapeutic applications. Purchasers assume responsibility for proper handling and compliance with all applicable laws and regulations.  Learn More

    bottom of page